Reduce Inefficiencies in Management of Spasticity
Sponsored by The University of Texas Health Science Center, Houston
About this study
The purpose of this study is to evaluate the effectiveness of a spasticity screener and to determine if the spasticity screener results are useful to healthcare providers and impact clinical decision making
Where this study is enrolling
- I'm interested
The University of Texas Health Science Center at Houston PO Box 20036
Houston, Texas
Who can participate
Inclusion criteria
- ✓Currently admitted for an acute hemorrhagic or ischemic stroke; recurrent stroke allowed if no spasticity at baseline
- ✓NIHSS score of \> 0 on items 5 or 6 (required of at least 1 limb)
- ✓Willingness to participate in the study for 24 months
- ✓Able to sign consent form or availability of a legally authorized representative to sign
- ✓Able to read/write in English
- ✓Identified MD for follow up post hospitalization
Exclusion criteria
- ✕Botulinum toxin use for any indication within the past 12 weeks
- ✕Acute life threatening illness
- ✕Prior limb injury or neurological diagnosis that limited movement in the now affected limb(s)
- ✕Any terminal illness that would limit participation in study follow ups
- ✕Known spasticity or other movement disorders that impact tone
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.